Air microbubbles as MR susceptibility contrast agent at 1.5 Tesla.

Air microbubbles have been investigated recently at high magnetic field strength (2 Tesla or greater) as potential MR susceptibility contrast agents. We used a phantom to measure their susceptibility at 1.5 T to clarify their usefulness for this purpose. The phantom, filled with fresh Levovist suspension at 4 different doses (67 to 125 mg/mL), was continuously scanned with a gradient-echo technique at a temporal resolution of 10 s. The transverse relaxation increase (R2*) by microbubbles demonstrated a time course of exponential decay at each dose (time-constant, 39 to 57 s). The dependency of R2* on microbubble volume fraction was linear, with a slope of 89 s-1 per percentage microbubble volume fraction. Our study represents the first step towards applying microbubbles as susceptibility contrast agents at 1.5 T.

[1]  Y. R. Kim,et al.  In vivo study of microbubbles as an MR susceptibility contrast agent , 2004, Magnetic resonance in medicine.

[2]  A. Bjørnerud,et al.  Assessment of T1 and T  *2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state—dependence on blood volume and water exchange , 2002, Magnetic resonance in medicine.

[3]  G. Wright,et al.  On the parameters affecting the sensitivity of MR measures of pressure with microbubbles , 2002, Magnetic resonance in medicine.

[4]  J. Jensen,et al.  NMR relaxation in tissues with weak magnetic inhomogeneities , 2000, Magnetic resonance in medicine.

[5]  W N McDicken,et al.  An in vitro comparison of ultrasonic contrast agents in solutions with varying air levels. , 2000, Ultrasound in medicine & biology.

[6]  S. Posse,et al.  Analytical model of susceptibility‐induced MR signal dephasing: Effect of diffusion in a microvascular network , 1999, Magnetic resonance in medicine.

[7]  J C Gore,et al.  Asymmetric spin‐echo imaging of magnetically inhomogeneous systems: Theory, experiment, and numerical studies , 1998, Magnetic resonance in medicine.

[8]  R. Manfredi,et al.  New prospects for ultrasound contrast agents. , 1998, European journal of radiology.

[9]  A. Gmitro,et al.  Microbubbles as novel pressure‐sensitive MR contrast agents , 1996, Magnetic resonance in medicine.

[10]  J. Bulte,et al.  Comparison of t2 relaxation in blood, brain, and ferritin , 1995, Journal of magnetic resonance imaging : JMRI.

[11]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[12]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[13]  K. Uğurbil,et al.  Contrast agents for cerebral perfusion MR imaging , 1994, Journal of magnetic resonance imaging : JMRI.

[14]  J. Gore,et al.  Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.